There is scientific evidence that patients with hs-CRP values > 2 mg/L measured 30 days post-AMI (indicating persistent inflammatory response after the acute phase) have a two-fold increase in the risk of a new heart failure (HF) or of the worsening of an existing heart failure over the following 2 years [13,16]. This evidence concerns the gene CRP and heart failure.